Dahili, Baby Boy .

HRN: 28-53-83  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/15/2026
AMPICILLIN 250MG (VIAL)
02/15/2026
02/22/2026
IV
180MG
Q12H
PNSB
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Bloodstream    Compliance to guidelines: